Intravitreal Bevacizumab for Treatment of Uveitic Macular Edema

Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

Robert L. Avery, Dante J. Pieramici, Melvin Rabena et al. · Ophthalmology · 2006 · 1.1K citations

Medicine, Ophthalmology, Pharmacotherapy +14

Optical Coherence Tomography Findings After an Intravitreal Injection of Bevacizumab (Avastin®) for Neovascular Age-Related Macular Degeneration

Philip J. Rosenfeld, Andrew A. Moshfeghi, Carmen A. Puliafito · Ophthalmic surgery, lasers & imaging retina · 2005 · 907 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Causes and frequency of blindness in patients with intraocular inflammatory disease.

Aniki Rothová, M S Suttorp-van Schulten, W F Treffers et al. · British Journal of Ophthalmology · 1996 · 902 citations · Full text

Medicine, Ophthalmology, Ocular Disease +13

Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular DegenerationTwelve-Week Results of an Uncontrolled Open-Label Clinical Study

S. Michels, Philip J. Rosenfeld, C PULIAFITO et al. · Ophthalmology · 2005 · 669 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for macular edema from central retinal vein occlusion.

Philip J. Rosenfeld, Anne E. Fung, Carmen A. Puliafito · PubMed · 2005 · 469 citations

Medicine, Ophthalmology, Vision Science +16